Eurobio Scientific Société anonyme (EPA:ALERS)

Market Cap	250.86M
Revenue (ttm)	154.95M
Net Income (ttm)	4.00M
Shares Out	10.03M
EPS (ttm)	0.39
PE Ratio	64.18
Forward PE	21.55
Dividend	n/a
Ex-Dividend Date	n/a

Volume	570
Average Volume	383
Open	24.95
Previous Close	25.00
Day's Range	24.95 - 25.40
52-Week Range	23.20 - 26.50
Beta	0.38
RSI	46.14
Earnings Date	Jul 25, 2025

About Stericycle

Eurobio Scientific Société anonyme engages in the design, development, and commercialization of in vitro diagnostics products in the areas of transplantation, immunology, infectious diseases, life-science, and cancer. It commercializes media for the transportation and preservation of cornea grafts, as well as a device to facilitate the corresponding surgery; AlloMap, a molecular test for the surveillance of heart-transplant patients; cell culture media, molecular biology reagents, and proprietary antibodies; TQS (Tetanus Quick Stick) for the ev...

• Industry: Medical Devices
• Sector: Healthcare
• Founded: 1997
• Employees: 326
• Stock Exchange: Euronext Paris
• Ticker Symbol: ALERS

Financial Performance

In 2024, EPA:ALERS's revenue was 154.95 million, an increase of 18.60% compared to the previous year's 130.65 million. Earnings were 4.00 million, a decrease of -17.31%.